Kati Rohtla

Kati Rohtla, MBA, has a diverse work experience spanning over several companies. Kati currently works as the Senior Program Director for Program & Portfolio Management at Cerevel Therapeutics since 2022. Prior to this, Rohtla held multiple roles at Vertex Pharmaceuticals from 2017 to 2022, including Director of Regulatory Management Office, Director of Regulatory Submission Management, and Associate Director of Regulatory Submissions Management.

Before joining Vertex Pharmaceuticals, Rohtla worked at Biogen from 2001 to 2017. Kati'sroles at Biogen included Associate Director of Resource and Performance Management, Clinical Filing Project Manager, Associate Director of Biometrics Operations, Senior Manager of Biometrics Operations, Sr. Analyst III of Statistical Submission Management, and Statistical Submission Management Specialist.

Rohtla began their career at Kendle International Inc in 1998 as a Senior Clinical Programmer/Analyst, where they served as the Lead Programmer on multiple projects. Kati then worked as a Project Coordinator at Beth Israel Deaconess Medical Center, Institute for Prevention of Cardiovascular Disease from 1996 to 1998.

Overall, Rohtla's work experience showcases their expertise in program and portfolio management, regulatory management, biometrics operations, and clinical research.

Kati Rohtla completed their Bachelor's degree in Exercise Physiology from Boston University between 1992 and 1996. Later, they pursued their Master of Business Administration (MBA) from Worcester Polytechnic Institute, which they successfully obtained between 2014 and 2018.